Novel pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors

Details for Australian Patent Application No. 2005284098 (hide)

Owner Addex Pharma SA OrthoMcNeil-Janssen Pharmaceuticals, Inc.

Inventors Finn, Terry Patrick; Nhem, Vanthea; Duvey, Guillaume Albert Jacques; Rocher, Jean-Philippe Francois Christian; Imogai, Hassan Julien; Le Poul, Emmanuel Christian; Bolea, Christelle Martine; Cid-Nunez, Jose Maria; Lutjens, Robert Johannes

Agent Davies Collison Cave

Pub. Number AU-B-2005284098

PCT Pub. Number WO2006/030032

Priority 0420722.1 17.09.04 GB

Filing date 16 September 2005

Wipo publication date 23 March 2006

Acceptance publication date 16 June 2011

International Classifications

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 241/18 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07F 7/08 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/030032 Priority application(s): WO2006/030032

29 November 2007 Change of Name(s) of Applicant(s), Section 104

  Janssen Pharmaceutica N.V.; Addex Pharmaceuticals SA The name of the applicant has been changed to Janssen Pharmaceutica N.V.; Addex Pharma SA

22 January 2009 Assignment before Grant

  Janssen Pharmaceutica N.V.; Addex Pharma SA The application has been assigned to Addex Pharma SA; OrthoMcNeil-Janssen Pharmaceuticals, Inc.

16 June 2011 Application Accepted

  Published as AU-B-2005284098

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005284103-Improved submersible farm

2005284097-Novel thieno-pyridine and thienopyrimidine derivatives and their use as positive allosteric modulators of mGluR2-receptors